Development and Preclinical Characterization of an Fc-Optimized CD133 Antibody for Induction of NK Cell Reactivity Against Myeloid Leukemia

被引：2
|
作者：
Koerner, Samuel [1 ]
Leibold, Julia [1 ]
Grosse-Hovest, Ludger [2 ]
Buehring, Hans-Joerg [1 ]
Jung, Gundram [1 ]
Kanz, Lothar [3 ]
Salih, Helmut R. [1 ,4 ,5 ]
机构：
[1] Univ Tubingen, Tubingen, Germany
[2] SYNIMMUNE GmbH, Tubingen, Germany
[3] Univ Hosp Tuebingen, Tubingen, Germany
[4] German Canc Consortium DKTK, Heidelberg, Germany
[5] German Canc Res Ctr, Heidelberg, Germany
来源：
BLOOD | 2014年 / 124卷 / 21期
关键词：
D O I：
10.1182/blood.V124.21.2309.2309
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Development and preclinical characterization of an Fc-optimized CD133 antibody for improved induction of NK cell reactivity against myeloid leukemia
    Koerner, Samuel
    Leibold, Julia
    Grosse-Hovest, Ludger
    Buehring, Hans-Joerg
    Salih, Helmut R.
    Jung, Gundram
    CANCER RESEARCH, 2014, 74 (19)
  • [2] An Fc-optimized CD133 antibody for induction of NK cell reactivity against myeloid leukemia
    Koerner, S. P.
    Andre, M. C.
    Leibold, J. S.
    Kousis, P. C.
    Kuebler, A.
    Pal, M.
    Haen, S. P.
    Buehring, H-J
    Grosse-Hovest, L.
    Jung, G.
    Salih, H. R.
    LEUKEMIA, 2017, 31 (02) : 459 - 469
  • [3] An Fc-optimized CD133 antibody for induction of NK cell reactivity against myeloid leukemia
    S P Koerner
    M C André
    J S Leibold
    P C Kousis
    A Kübler
    M Pal
    S P Haen
    H-J Bühring
    L Grosse-Hovest
    G Jung
    H R Salih
    Leukemia, 2017, 31 : 459 - 469
  • [4] Generation and preclinical characterization of an Fc-optimized CD133 antibody for improved induction of NK cell reactivity against myeloid leukemia
    Koerner, S.
    Leibold, J.
    Grosse-Hovest, L.
    Buehring, H. -J
    Kanz, L.
    Jung, G.
    Salih, H.
    ONKOLOGIE, 2013, 36 : 271 - 271
  • [5] Induction of NK cell reactivity against myeloid leukemia by a novel Fc-optimized CD133 antibody
    Schmied, B. J.
    Andre, M.
    Koerner, S.
    Leibold, J.
    Buehring, H. -J
    Haen, S.
    Kuebler, A.
    Kanz, L.
    Grosse-Hovest, L.
    Jung, G.
    Salih, H. R.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 135 - 135
  • [6] Induction of NK Cell Reactivity Against Myeloid Leukemia By a Novel Fc-Optimized CD133 Antibody
    Rothfelder, Kathrin
    Koerner, Samuel
    Andre, Maya
    Leibold, Julia
    Kousis, Philaretos
    Buehring, Hans-Joerg
    Haen, Sebastian P.
    Kuebler, Ayline
    Kanz, Lothar
    Grosse-Hovest, Ludger
    Jung, Gundram
    Salih, Helmut R.
    BLOOD, 2015, 126 (23)
  • [7] Induction of NK cell reactivity against myeloid leukemia by a novel Fc-optimized CD133 antibody
    Rothfelder, K.
    Koerner, S.
    Leibold, J.
    Kousis, P.
    Buehring, H-J
    Haen, S.
    Kuebler, A.
    Andre, M.
    Jung, G.
    Kanz, L.
    Grosse-Hovest, L.
    Salih, H. R.
    Oncology Research and Treatment, 2015, 38 : 259 - 259
  • [8] Generation and preclinical characterization of an Fc-optimized CD133 antibody for improved induction of NK cell reactivity against solid tumors
    Koerner, S.
    Leibold, J.
    Grosse-Hovest, L.
    Buehring, H-J
    Jung, G.
    Kanz, L.
    Salih, H. R.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 112 - 112
  • [9] An Fc-Optimized CD133 Antibody for Induction of NK Cell Reactivity against B Cell Acute Lymphoblastic Leukemia
    Riegg, Fabian
    Lutz, Martina S.
    Schmied, Bastian J.
    Heitmann, Jonas S.
    Queudeville, Manon
    Lang, Peter
    Jung, Gundram
    Salih, Helmut R.
    Maerklin, Melanie
    CANCERS, 2021, 13 (07)
  • [10] An Fc-Optimized CD133 Antibody for Induction of Natural Killer Cell Reactivity Against Colorectal Cancer
    Schmied, Bastian J.
    Riegg, Fabian
    Zekri, Latifa
    Grosse-Hovest, Ludger
    Buehring, Hans-Joerg
    Jung, Gundram
    Salih, Helmut R.
    CANCERS, 2019, 11 (06):
12345